NCT03768466View on ClinicalTrials.gov

Efficacy and Safety of Oxycodone/Naloxone (Targin®) in Persistent Moderate to Severe Low Back Pain Following NSAIDs Treatment

PHASE4CompletedINTERVENTIONAL

Enrollment

123

Participants

Timeline

Start Date

November 21, 2018

Primary Completion Date

February 20, 2020

Study Completion Date

September 17, 2020

Conditions

Low Back Pain

Interventions

DRUG

Brand Name: Targin®

Brand Name: Targin® Generic name: Oxycodone/Naloxone dosage form: Oral

Trial Locations (2)

05505

Asan Medical Center, Seoul

07061

SMG-SNU Boramae Medical Center, Seoul

All Listed Sponsors

lead

Mundipharma Korea Ltd

INDUSTRY

NCT03768466 - Efficacy and Safety of Oxycodone/Naloxone (Targin®) in Persistent Moderate to Severe Low Back Pain Following NSAIDs Treatment | Biotech Hunter | Biotech Hunter